BOTH IMMUNITY AND HYPERRESPONSIVENESS TO PNEUMOCYSTIS-CARINII RESULT FROM TRANSFER OF CD4+ BUT NOT CD8+ T-CELLS INTO SEVERE COMBINED IMMUNODEFICIENCY MICE

被引:135
作者
ROTHS, JB [1 ]
SIDMAN, CL [1 ]
机构
[1] JACKSON LAB, BAR HARBOR, ME 04609 USA
关键词
AIDS; PNEUMONIA; OPPORTUNISTIC INFECTION; ANTIBODY; THERAPY;
D O I
10.1172/JCI115910
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The opportunistic pathogen Pneumocystis carinii(Pc) is considered to be the leading cause of morbidity in patients with AIDS. It is important, therefore, to determine the immunological mechanisms of resistance to Pc. We have taken advantage of the lack of both T and B lymphocytes in severe combined immunodeficiency (scid) mice to determine the critical factors in resistance to spontaneously acquired Pc pneumonia. Using adoptive transfer of unfractionated or fractionated lymphocyte subsets or hyperimmune serum from congenic normal donors, we have demonstrated that effective immunity to Pc results from the action of CD4+ but not CD8+ T cells (in the absence of antibody) or from humoral immunity (in the absence of T cells). However, responses of CD4+ T cells (but not antibody) to already well-established burdens of Pc are often accompanied by a fatal hyperinflammatory reaction. The activity of CD4+ T cells against Pc thus illustrates a broadly applicable principle that T cell immunity represents a critical balance between consequences beneficial and harmful to the host.
引用
收藏
页码:673 / 678
页数:6
相关论文
共 43 条
[1]   HIGH-DOSE CORTICOSTEROID-THERAPY FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
AMUNDSON, DE ;
MURRAY, KM ;
BRODINE, S ;
OLDFIELD, EC .
SOUTHERN MEDICAL JOURNAL, 1989, 82 (06) :711-&
[2]  
BANCROFT GJ, 1989, CURR TOP MICROBIOL, V152, P235
[3]  
Bosma M. J., 1989, Immune-deficient animals in experimental medicine., P1
[4]  
BREEL M, 1988, IMMUNOLOGY, V63, P657
[5]  
BRUNVAND MW, 1991, CANCER, V67, P2407, DOI 10.1002/1097-0142(19910501)67:9<2407::AID-CNCR2820670932>3.0.CO
[6]  
2-X
[7]  
CUSTER RP, 1985, AM J PATHOL, V120, P464
[8]  
CZITROM AA, 1985, J IMMUNOL, V134, P2276
[9]  
DARLING G, 1990, CANCER RES, V50, P4008
[10]  
DORSHKIND K, 1984, J IMMUNOL, V132, P1804